Source:http://linkedlifedata.com/resource/pubmed/id/18496506
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2008-10-1
|
pubmed:abstractText |
Bone morphogenetic protein-7 (BMP-7) is a potential therapeutic agent for acute and chronic renal diseases. Here we found that addition of polymeric IgA, isolated from patients with IgA nephropathy, increased the synthesis of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), transforming growth factor-beta (TGF-beta) and fibronectin in cultured human mesangial cells, effects blunted by BMP-7. When mesangial cells were cultured with both polymeric IgA and BMP-7 there was an increase in the expression of peroxisome proliferator-activated receptor-gamma (PPAR-gamma). The activation of NF kappaB and TNF-alpha synthesis induced by polymeric IgA or TNF-alpha were downregulated by BMP-7 or rosiglitazone. BMP-7 inhibited TNF-alpha release from polymeric IgA-stimulated mesangial cells by activation of PPAR-gamma but suppressed TGF-beta release by mechanisms independent of PPAR-gamma. The expression of inhibitory Smad6 and 7 was increased whereas the expression of active Smad2 and 3 was reduced in these mesangial cells by BMP-7. Our study shows that BMP-7 ameliorates IgA nephropathy-derived polymeric IgA-induced TNF-alpha and TGF-beta synthesis in human mesangial cells through multiple mechanisms involving inhibitory Smads and PPAR-gamma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Protein 7,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin A,
http://linkedlifedata.com/resource/pubmed/chemical/PPAR gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Smad Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/polymeric IgA
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1523-1755
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1026-39
|
pubmed:meshHeading |
pubmed-meshheading:18496506-Bone Morphogenetic Protein 7,
pubmed-meshheading:18496506-Cells, Cultured,
pubmed-meshheading:18496506-Female,
pubmed-meshheading:18496506-Glomerulonephritis, IGA,
pubmed-meshheading:18496506-Humans,
pubmed-meshheading:18496506-Immunoglobulin A,
pubmed-meshheading:18496506-Male,
pubmed-meshheading:18496506-Mesangial Cells,
pubmed-meshheading:18496506-PPAR gamma,
pubmed-meshheading:18496506-Smad Proteins,
pubmed-meshheading:18496506-Transforming Growth Factor beta,
pubmed-meshheading:18496506-Tumor Necrosis Factor-alpha
|
pubmed:year |
2008
|
pubmed:articleTitle |
BMP-7 protects mesangial cells from injury by polymeric IgA.
|
pubmed:affiliation |
Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|